companiesSEC EDGAR
4D Molecular Therapeutics, Inc.

SEC EDGAR published this disclosure on 2026-08-13. Read the original document for its full text and supporting detail.
Open the original document at SEC EDGAR ↗accession0001193125-26-349173
cik1650648
company name4D Molecular Therapeutics, Inc.
form10-Q